Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | Pinatuzumab Vedotin |
Trade Name | |
Synonyms | DCDT2980S |
Drug Descriptions |
Pinatuzumab Vedotin (DCDT2980S) is an antibody drug conjugate (ADC) comprising a monoclonal antibody against CD22 attached to the drug monomethyl auristatin E, potentially resulting in increased death of CD22-positive tumor cells (PMID: 25708834, PMID: 30935953). |
DrugClasses | |
CAS Registry Number | 1313706-14-7 |
NCIT ID | C104167 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Obinutuzumab + Pinatuzumab Vedotin + Rituximab | Obinutuzumab Pinatuzumab Vedotin Rituximab | 0 | 1 |
Pinatuzumab Vedotin | Pinatuzumab Vedotin | 0 | 0 |
Pinatuzumab Vedotin + Polatuzumab vedotin-piiq + Rituximab | Pinatuzumab Vedotin Polatuzumab vedotin-piiq Rituximab | 0 | 1 |
Pinatuzumab Vedotin + Rituximab | Pinatuzumab Vedotin Rituximab | 0 | 0 |